# FNCHQ (Finch Therapeutics Group, Inc.) - SEC EDGAR Financial Statements

> Finch Therapeutics Group, Inc. reported $0 in revenue and a net loss of $14.17M for the trailing twelve months ended June 30, 2024 (down 87.6% year over year).

- Canonical: https://convexityos.com/fundamentals/FNCHQ
- Markdown: https://convexityos.com/fundamentals/FNCHQ.md
- SEC CIK: 0001733257
- Reporting currency: USD
- Latest filing period: June 30, 2024
- Last synced: Nov 21, 2026, 05:04 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001733257&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $0 | -87.6% YoY |
| Operating Income | TTM | -$19.50M | Operating profit |
| Net Income | TTM | -$14.17M | GAAP bottom line |
| Diluted EPS | TTM | -$8.82 | Split-adjusted |
| Free Cash Flow | TTM | -$18.04M | Operating CF less CapEx |
| Cash & ST Investments | Jun 30, 2024 | $16.04M | Total debt: $28.99M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- |
| **Revenue** | $107K | $861K | $18.53M | $7.72M |
| Research & Development | $7.20M | $52.86M | $57.28M | $33.14M |
| Total Operating Expenses | $83.97M | $116.5M | $78.52M | $47.16M |
| **Operating Income** | -$83.86M | -$115.6M | -$59.98M | -$39.44M |
| **EBITDA** | -$82.34M | -$110.1M | -$57.68M | -$38.65M |
| Income Before Tax | -$78.22M | -$114.6M | -$58.16M | -$39.34M |
| Income Tax Expense | -$3.46M | $0 | $0 | $0 |
| **Net Income** | -$74.75M | -$114.6M | -$58.16M | -$39.34M |
| Basic EPS | -$46.59 | -$72.12 | -$44.44 | -$145.04 |
| **Diluted EPS** | -$46.59 | -$72.12 | -$44.44 | -$145.04 |
| Basic Shares Outstanding | 1.6M | 1.6M | 1.3M | 271.2K |
| Diluted Shares Outstanding | 1.6M | 1.6M | 1.3M | 271.2K |

### Income Statement (Quarterly)

| Line Item | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $0 | $0 | $0 | $107K | $8.0K | $138K |
| Research & Development | $0 | $0 | $0 | $0 | $203K | $7.00M | $11.55M | $11.86M |
| Total Operating Expenses | $6.11M | $5.20M | $4.42M | $3.78M | $9.88M | $65.89M | $27.76M | $40.77M |
| **Operating Income** | -$6.11M | -$5.20M | -$4.42M | -$3.78M | -$9.88M | -$65.78M | -$27.75M | -$40.63M |
| **EBITDA** | -$6.07M | -$5.16M | -$4.37M | -$3.73M | -$9.82M | -$64.42M | -$26.34M | -$39.23M |
| Income Before Tax | -$4.83M | -$3.88M | -$3.04M | -$2.42M | -$6.95M | -$65.81M | -$27.01M | -$40.37M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | -$3.46M | $0 | $0 |
| **Net Income** | -$4.83M | -$3.88M | -$3.04M | -$2.42M | -$6.95M | -$62.35M | -$27.01M | -$40.37M |
| Basic EPS | -$3.01 | -$2.41 | -- | -$1.51 | -$4.33 | -$39.19 | -- | -$25.38 |
| **Diluted EPS** | -$3.01 | -$2.41 | -- | -$1.51 | -$4.33 | -$39.19 | -- | -$25.38 |
| Basic Shares Outstanding | 1.6M | 1.6M | -- | 1.6M | 1.6M | 1.6M | -- | 1.6M |
| Diluted Shares Outstanding | 1.6M | 1.6M | -- | 1.6M | 1.6M | 1.6M | -- | 1.6M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $25.12M | $71.04M | $133.5M | $99.71M |
| **Cash & Short-Term Investments** | $25.12M | $71.04M | $133.5M | $99.71M |
| Accounts Receivable, Net | $0 | $144K | $494K | $1.03M |
| **Total Current Assets** | $25.85M | $74.55M | $142.6M | $106.2M |
| Property, Plant & Equipment, Net | $594K | $15.94M | $19.64M | $7.00M |
| Goodwill | -- | $0 | $18.06M | $18.06M |
| Other Non-Current Assets | $0 | $4.03M | $4.91M | $200K |
| **Total Non-Current Assets** | $29.53M | $88.39M | $82.82M | $59.17M |
| **Total Assets** | $55.37M | $162.9M | $225.4M | $165.3M |
| Accounts Payable | $141K | $1.10M | $3.74M | $2.62M |
| Deferred Revenue (Current) | -- | -- | $0 | $3.37M |
| **Total Current Liabilities** | $4.08M | $14.69M | $14.79M | $11.49M |
| Long-Term Debt | $0 | $14.65M | $0 | $1.81M |
| Deferred Revenue (Non-Current) | -- | -- | $0 | $10.26M |
| Other Non-Current Liabilities | $0 | $170K | $7.0K | $221K |
| **Total Non-Current Liabilities** | $28.40M | $52.54M | $8.36M | $16.52M |
| **Total Liabilities** | $32.49M | $67.23M | $23.14M | $28.00M |
| **Total Debt (incl. Leases)** | $30.13M | $52.34M | $6.04M | $1.81M |
| Common Stock | $2.0K | $2.0K | $47K | $8.0K |
| Retained Earnings | -$350.4M | -$275.6M | -$161.0M | -$102.8M |
| **Total Stockholders' Equity** | $22.89M | $95.71M | $202.2M | -$95.72M |
| Total Equity | $22.89M | $95.71M | $202.2M | -$95.72M |

### Balance Sheet (Quarterly)

| Line Item | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $16.04M | $20.76M | $25.12M | $28.78M | $34.05M | $41.68M | $71.04M | $85.29M |
| **Cash & Short-Term Investments** | $16.04M | $20.76M | $25.12M | $28.78M | $34.05M | $41.68M | $71.04M | $85.29M |
| Accounts Receivable, Net | -- | -- | $0 | $0 | $0 | $107K | $144K | $0 |
| **Total Current Assets** | $17.28M | $21.18M | $25.85M | $29.92M | $36.50M | $43.40M | $74.55M | $90.62M |
| Property, Plant & Equipment, Net | $507K | $551K | $594K | $637K | $732K | $1.25M | $15.94M | $17.28M |
| Goodwill | -- | -- | -- | -- | -- | -- | $0 | $0 |
| Other Non-Current Assets | -- | -- | $0 | $0 | $0 | $200K | $4.03M | $4.25M |
| **Total Non-Current Assets** | $28.30M | $28.92M | $29.53M | $29.57M | $30.36M | $35.64M | $88.39M | $97.35M |
| **Total Assets** | $45.58M | $50.09M | $55.37M | $59.49M | $66.86M | $79.04M | $162.9M | $188.0M |
| Accounts Payable | $29K | $47K | $141K | $357K | $432K | $2.55M | $1.10M | $1.06M |
| **Total Current Liabilities** | $4.46M | $3.50M | $4.08M | $4.88M | $9.57M | $13.21M | $14.69M | $13.81M |
| Long-Term Debt | -- | -- | $0 | $0 | $0 | $0 | $14.65M | $14.64M |
| Other Non-Current Liabilities | -- | -- | $0 | $0 | $0 | $0 | $170K | $125K |
| **Total Non-Current Liabilities** | $26.89M | $27.55M | $28.40M | $28.80M | $29.39M | $32.88M | $52.54M | $53.29M |
| **Total Liabilities** | $31.36M | $31.05M | $32.49M | $33.68M | $38.96M | $46.09M | $67.23M | $67.10M |
| **Total Debt (incl. Leases)** | $28.99M | $29.56M | $30.13M | $30.77M | $31.04M | $36.13M | $52.34M | $52.36M |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $48K | $2.0K | $48K |
| Retained Earnings | -$359.1M | -$354.3M | -$350.4M | -$347.4M | -$344.9M | -$339.6M | -$275.6M | -$248.6M |
| **Total Stockholders' Equity** | $14.22M | $19.04M | $22.89M | $25.81M | $27.89M | $34.54M | $95.71M | $120.9M |
| Total Equity | $14.22M | $19.04M | $22.89M | $25.81M | $27.89M | $34.54M | $95.71M | $120.9M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- |
| Net Income | -$74.75M | -$114.6M | -$58.16M | -$39.34M |
| Depreciation & Amortization | $1.52M | $5.51M | $2.30M | $790K |
| Stock-Based Compensation | $1.93M | $7.84M | $4.16M | $3.10M |
| Change in Receivables | $143K | $350K | $540K | $143K |
| Change in Payables | -$956K | -$2.26M | $2.26M | $440K |
| **Operating Cash Flow** | -$31.50M | -$74.85M | -$67.13M | -$31.33M |
| Capital Expenditure | $0 | -$2.18M | -$15.98M | -- |
| **Free Cash Flow** | -$31.50M | -$77.03M | -$83.12M | -- |
| **Investing Cash Flow** | $1.33M | -$2.18M | -$15.92M | -$2.63M |
| **Financing Cash Flow** | -$16.16M | $14.87M | $119.1M | $91.47M |
| **Net Change in Cash** | -$46.33M | -$62.16M | $36.06M | $57.51M |

### Cash Flow Statement (Quarterly)

| Line Item | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$4.83M | -$3.88M | -$3.04M | -$2.42M | -$6.95M | -$62.35M | -$27.01M | -$40.37M |
| Depreciation & Amortization | $44K | $43K | $44K | $52K | $57K | $1.37M | $1.41M | $1.41M |
| Stock-Based Compensation | $15K | $28K | $114K | $335K | $300K | $1.18M | $1.79M | $2.10M |
| Change in Receivables | $0 | $0 | -$1.0K | $0 | $107K | $37K | -$144K | $174K |
| Change in Payables | -$18K | -$94K | -$216K | -$76K | -$528K | -$136K | $37K | $135K |
| **Operating Cash Flow** | -$4.73M | -$4.36M | -$3.71M | -$5.26M | -$9.16M | -$13.38M | -$14.27M | -$19.09M |
| Capital Expenditure | $0 | $0 | $14K | $0 | $0 | -$14K | -$51K | -$328K |
| **Free Cash Flow** | -$4.73M | -$4.36M | -$3.69M | -$5.26M | -$9.16M | -$13.39M | -$14.32M | -$19.42M |
| **Investing Cash Flow** | $0 | $0 | $51K | $20K | $1.27M | -$14K | -$51K | -$328K |
| **Financing Cash Flow** | $0 | $0 | $0 | $0 | $4.0K | -$16.16M | $52K | $41K |
| **Net Change in Cash** | -$4.73M | -$4.36M | -$3.65M | -$5.24M | -$7.88M | -$29.55M | -$14.27M | -$19.38M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- |
| **Operating Margin** | -78374.8% | -13425.4% | -323.7% | -510.9% |
| **Net Profit Margin** | -69863.6% | -13315.4% | -313.8% | -509.7% |
| Return on Equity (ROE) | -326.6% | -119.8% | -28.8% | -- |
| Return on Assets (ROA) | -135.0% | -70.4% | -25.8% | -23.8% |
| Current Ratio | 6.33x | 5.08x | 9.64x | 9.24x |
| Quick Ratio | 6.15x | 4.85x | 9.06x | 8.77x |
| Debt to Equity | 1.32x | 0.55x | 0.03x | -- |
| **Revenue Growth (YoY)** | -87.6% | -95.4% | +140.1% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -78374.8% | -93214.8% | -56936.0% | -25536.8% | -13425.4% | -6443.8% |
| **Net Profit Margin** | -- | -- | -69863.6% | -85844.3% | -54022.1% | -24825.1% | -13315.4% | -6431.2% |
| Return on Equity (ROE) | -99.6% | -85.5% | -326.6% | -382.4% | -490.0% | -441.3% | -119.8% | -88.3% |
| Return on Assets (ROA) | -31.1% | -32.5% | -135.0% | -165.9% | -204.4% | -192.8% | -70.4% | -56.8% |
| Current Ratio | 3.87x | 6.05x | 6.33x | 6.13x | 3.81x | 3.29x | 5.08x | 6.56x |
| Quick Ratio | 3.59x | 5.93x | 6.15x | 5.90x | 3.56x | 3.16x | 4.85x | 6.18x |
| Debt to Equity | 2.04x | 1.55x | 1.32x | 1.19x | 1.11x | 1.05x | 0.55x | 0.43x |
| **Revenue Growth (YoY)** | -- | -100.0% | -100.0% | -100.0% | -100.0% | -69.8% | -99.0% | -98.8% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
